Reduction of Β-amyloid deposits by γ-secretase inhibitor is associated with the attenuation of secondary damage in the ipsilateral thalamus and sensory functional improvement after focal cortical infarction in hypertensive rats

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 2, 2011, Pages 572-579

  Zhang, Yusheng ^a   Xing, Shihui ^a   Zhang, Jian ^a   Li, Jingjing ^a   Li, Chuo ^a   Pei, Zhong ^a   Zeng, Jinsheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

amyloid; cerebral infarction; g secretase inhibitor; rats; secondary damage; thalamus

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA SECRETASE INHIBITOR; N [N (3,5 DIFLUOROPHENACETYL)ALANYL] S PHENYL GLYCINE TERT BUTYL ESTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; GLIA; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY SYSTEM; THALAMUS LATERAL NUCLEUS;

AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL PROLIFERATION; CEREBRAL INFARCTION; COLORING AGENTS; DIPEPTIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; NEUROGLIA; NEURONS; PROTEASE INHIBITORS; RATS; RATS, INBRED SHR; RATS, SPRAGUE-DAWLEY; SENSATION; THALAMUS;

EID: 79551629454     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2010.127     Document Type: Article

References (40)

1. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-6
2. Block F, Dihne M, Loos M (2005) Inflammation in areas of remote changes following focal brain lesion. Prog Neurobiol 75:342-65
3. Clarke J, Thornell A, Corbett D, Soininen H, Hiltunen M, Jolkkonen J (2007) Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats. Eur J Neurosci 26:1845-52
4. Comery TA, Martone RL, Aschmies S, Atchison KP, Diamantidis G, Gong X, Zhou H, Kreft AF, Pangalos MN, Sonnenberg-Reines J, Jacobsen JS, Marquis KL (2005) Acute gamma-secretase inhibition improves contextual fear conditioning in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 25:8898-902
5. Dihne M, Grommes C, Lutzenburg M, Witte OW, Block F (2002) Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke 33:3006-11
6. Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM, Paul SM (2002) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5:452-7
7. Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P, Fang LY, Freedman SB, Folmer B, Goldbach E, Holsztynska EJ, Hu KL, Johnson-Wood KL, Kennedy SL, Kholodenko D, Knops JE, Latimer LH, Lee M, Liao Z, Lieberburg IM, Motter RN, Mutter LC, Nietz J, Quinn KP, Sacchi KL, Seubert PA, Shopp GM, Thorsett ED, Tung JS, Wu J, Yang S, Yin CT, Schenk DB, May PC, Altstiel LD, Bender MH, Boggs LN, Britton TC, Clemens JC, Czilli DL, Dieckman-McGinty DK, Droste JJ, Fuson KS, Gitter BD, Hyslop PA, Johnstone EM, Li WY, Little SP, Mabry TE, Miller FD, Audia JE (2001) Functional gamma-secretase inhibitors reduce beta-amyloid pep-tide levels in brain. J Neurochem 76:173-81
8. El Mouedden M, Vandermeeren M, Meert T, Mercken M (2006) Reduction of Abeta levels in the Sprague Dawley rat after oral administration of the functional gamma- secretase inhibitor, DAPT: a novel non-transgenic model for Abeta production inhibitors. Curr Pharm Des 12:671-6
9. Estus S, Tucker HM, van Rooyen C, Wright S, Brigham EF, Wogulis M, Rydel RE (1997) Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant 'apoptotic' pattern of gene induction. J Neurosci 17:7736-45
10. Freret T, Chazalviel L, Roussel S, Bernaudin M, Schumann-Bard P, Boulouard M (2006) Long-term functional outcome following transient middle cerebral artery occlusion in the rat: correlation between brain damage and behavioral impairment. Behav Neurosci 120:1285-98
11. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ (2001) Primary prevention of ischemic stroke-a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 32:280-99
12. He M, Xing S, Yang B, Zhao L, Hua H, Liang Z, Zhou W, Zeng J, Pei Z (2007) Ebselen attenuates oxidative DNA damage and enhances its repair activity in the thalamus after focal cortical infarction in hypertensive rats. Brain Res 1181:83-92
13. Hiltunen M, Makinen P, Peraniemi S, Sivenius J, van Groen T, Soininen H, Jolkkonen J (2009) Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus. Neurobiol Dis 35:103-13
14. Iizuka H, Sakatani K, Young W (1990) Neural damage in the rat thalamus after cortical infarcts. Stroke 21:790-4
15. Kataoka K, Hayakawa T, Yamada K, Mushiroi T, Kuroda R, Mogami H (1989) Neuronal network disturbance after focal ischemia in rats. Stroke 20:1226-35
16. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotox-ins. Proc Natl Acad Sci USA 95:6448-53
17. Lanz TA, Himes CS, Pallante G, Adams L, Yamazaki S, Amore B, Merchant KM (2003) The gamma-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S- phenyl-glycine t-butyl ester reduces Abeta levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice. J Pharmacol Exp Ther 305:864-71
18. Liang Z, Zeng J, Liu S, Ling X, Xu A, Yu J, Ling L (2007) A prospective study of secondary degeneration following subcortical infarction using diffusion tensor imaging. J Neurol Neurosurg Psychiatry 78:581-6
19. Ling L, Zeng J, Pei Z, Cheung RT, Hou Q, Xing S, Zhang S (2009) Neurogenesis and angiogenesis within the ipsi-lateral thalamus with secondary damage after focal cortical infarction in hypertensive rats. J Cereb Blood Flow Metab 29:1538-46
20. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, Caspersen C, Chen X, Pollak S, Chaney M, Trinchese F, Liu S, Gunn-Moore F, Lue LF, Walker DG, Kuppusamy P, Zewier ZL, Arancio O, Stern D, Yan SS, Wu H (2004) ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 304:448-52
21. Makinen S, van Groen T, Clarke J, Thornell A, Corbett D, Hiltunen M, Soininen H, Jolkkonen J (2008) Coaccumu-lation of calcium and beta-amyloid in the thalamus after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 28:263-8
22. Ross DT, Ebner FF (1990) Thalamic retrograde degeneration following cortical injury: an excitotoxic process? Neuroscience 35:525-50
23. Rupalla K, Allegrini PR, Sauer D, Wiessner C (1998) Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice. Acta Neuropathol 96:172-8
24. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack-a statement for healthcare professionals from the American Heart Association/ American Stroke Association Council on Stroke-Co-sponsored by the Council on Cardiovascular Radiology and Intervention-The American Academy of Neurology affirms the value of this guideline. Stroke 37:577-617 (Pubitemid 43732031)
25. Schallert T, Upchurch M, Wilcox RE, Vaughn DM (1983) Posture-independent sensorimotor analysis of inter-hemispheric receptor asymmetries in neostriatum. Pharmacol Biochem Behav 18:753-9
26. Schlachetzki JCM, Hull M (2009) Microglial activation in Alzheimer's disease. Curr Alzheimer Res 6:554-63
27. Schmahmann JD (2003) Vascular syndromes of the thala-mus. Stroke 34:2264-78
28. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-66
29. Soriano MA, Ferrer I, Rodriguez-Farre E, Planas AM (1996) Apoptosis and c-Jun in the thalamus of the rat following cortical infarction. Neuroreport 7:425-8
30. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-3
31. Tamura A, Tahira Y, Nagashima H, Kirino T, Gotoh O, Hojo S, Sano K (1991) Thalamic atrophy following cerebral infarction in the territory of the middle cerebral artery. Stroke 22:615-8
32. Van Groen T, Puurunen K, Maki HM, Sivenius J, Jolkkonen J (2005) Transformation of diffuse beta-amyloid precursor protein and beta-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 36:1551-6
33. Wang F, Liang Z, Hou Q, Xing S, Ling L, He M, Pei Z, Zeng J (2007) Nogo-A is involved in secondary axonal degeneration of thalamus in hypertensive rats with focal cortical infarction. Neurosci Lett 417:255-60
34. Watanabe H, Kumon Y, Ohta S, Sakaki S, Matsuda S, Sakanaka M (1998) Changes in protein synthesis and calcium homeostasis in the thalamus of spontaneously hypertensive rats with focal cerebral ischemia. J Cereb Blood Flow Metab 18:686-96
35. Wolfe MS (2002) Therapeutic strategies for Alzheimer's disease. Nat Rev Drug Discov 1:859-66
36. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005-15
37. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250:279-82
38. Yankner BA, Lu T (2009) Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 284:4755-9
39. Zeng J, Huang R, Su Z (1998a) Stroke-prone renovascular hypertensive rats. Chin Med J (Engl) 111:741-4
40. Zeng J, Zhang Y, Mo J, Su Z, Huang R (1998b) Two-kidney, two clip renovascular hypertensive rats can be used as stroke-prone rats. Stroke 29:1708-14